Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Maggiolo

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Antimicrobial Chemotherapy|September 22, 2009
Efavirenz: a decade of clinical experience in the treatment of HIVFranco Maggiolo
Expert Opinion on Pharmacotherapy|May 23, 2007
EfavirenzFranco Maggiolo
Lancet (London, England)|July 20, 2010
Is HAART modifying the HIV epidemic?Franco Maggiolo, Sebastiano Leone
Infectious Diseases and Therapy|August 20, 2014
Single-Tablet Regimens in HIV TherapyNoemi Astuti, Franco Maggiolo
Expert Opinion on Pharmacotherapy|September 13, 2016
Abacavir + dolutegravir + lamivudine for the treatment of HIVLaura Comi, Franco Maggiolo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infectionFranco Maggiolo, Sebastiano Leone
Current Opinion in Investigational Drugs (London, England : 2000)|July 31, 2008
Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionDiego Ripamonti, Franco Maggiolo
Patient Preference and Adherence|July 2, 2013
Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infectionClaudia Bernardini, Franco Maggiolo
Lancet (London, England)|April 28, 2004
HIV-1 and hepatitis B virus: time for a re-think?Diego Ripamonti, Franco Maggiolo, Fredy Suter
The Journal of Antimicrobial Chemotherapy|April 26, 2005
Switch strategies in patients on effective HAARTFranco Maggiolo, Diego Ripamonti, Fredy Suter
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Antimicrobial Chemotherapy|September 22, 2009
Efavirenz: a decade of clinical experience in the treatment of HIVFranco Maggiolo
Expert Opinion on Pharmacotherapy|May 23, 2007
EfavirenzFranco Maggiolo
Lancet (London, England)|July 20, 2010
Is HAART modifying the HIV epidemic?Franco Maggiolo, Sebastiano Leone
Infectious Diseases and Therapy|August 20, 2014
Single-Tablet Regimens in HIV TherapyNoemi Astuti, Franco Maggiolo
Expert Opinion on Pharmacotherapy|September 13, 2016
Abacavir + dolutegravir + lamivudine for the treatment of HIVLaura Comi, Franco Maggiolo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infectionFranco Maggiolo, Sebastiano Leone
Current Opinion in Investigational Drugs (London, England : 2000)|July 31, 2008
Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionDiego Ripamonti, Franco Maggiolo
Patient Preference and Adherence|July 2, 2013
Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infectionClaudia Bernardini, Franco Maggiolo
Lancet (London, England)|April 28, 2004
HIV-1 and hepatitis B virus: time for a re-think?Diego Ripamonti, Franco Maggiolo, Fredy Suter
The Journal of Antimicrobial Chemotherapy|April 26, 2005
Switch strategies in patients on effective HAARTFranco Maggiolo, Diego Ripamonti, Fredy Suter
Pageof 17